Previous 10 | Next 10 |
2023-07-20 08:29:22 ET Netcapital NCPL -42% on $1.2M equity offering . Gossamer Bio ( GOSS ) -21% announces $212 Million private placement financing . DURECT Corporation ( DRRX ) -19% announces $15 Million Registered Direct Offering . Jianzhi Ed...
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules PR Newswire CUPERTINO, Calif. , July 20, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developi...
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis PR Newswire Topline data anticipated in Q4 2023 CUPERTINO, Calif. , June 7, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmac...
2023-05-08 22:42:05 ET DURECT Corporation (DRRX) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive Officer Keith Lui - Senior Vice President, Business Development, Commercia...
2023-05-08 16:11:02 ET Durect press release ( NASDAQ: DRRX ): Q1 GAAP EPS of -$0.52 beats by $0.01 . Revenue of $2.1M (+9.4% Y/Y) misses by $1.09M . For further details see: Durect GAAP EPS of -$0.52 beats by $0.01, revenue of $2.1M misses by $1.09M
DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update PR Newswire - Webcast of Earnings Call Today, May 8th at 4:30 p.m. ET - Topline data from AHFIRM trial expected in 2H 2023 CUPERTINO, Calif. , May 8, 2...
DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8 PR Newswire CUPERTINO, Calif. , May 1, 2023 /PRNewswire/ --- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its first quarter 2023 ...
DURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis PR Newswire CUPERTINO, Calif. , April 27, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced it will host a Key Opinion Leader ("KOL") event on Alcohol-Associated Hepatitis on ...
DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference PR Newswire CUPERTINO, Calif. , April 25, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James Brown , President and ...
DURECT Corporation (NASDAQ: DRRX) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 9.88% on the day to $4.45. DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigeneti...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...